Cargando…

30.1 IMMUNE PATHOGENESIS OF PSYCHOSIS: THE CHALLENGE OF CO-MORBIDITY

BACKGROUND: The immune pathogenesis story of schizophrenia is gathering momentum, with increasing evidence from genetic, circulating biomarker and neuropathological studies. New treatment approaches are being trialled. However immune dysfunction is not unique to schizophrenia, and circulating proinf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Upthegrove, Rachel, Krynicki, Carl, Gordianno, Annalisa, Pariante, Carmine, Rowland, Toby, Barnes, Nicholas, Marwaha, Steven, Perry, Benjamin, Dazzan, Paola, Deakin, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888092/ http://dx.doi.org/10.1093/schbul/sby014.122

Ejemplares similares

Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers
por: Watson, Andrew J., et al.
Publicado: (2023)

T46. TARGETING THE IMMUNE SYSTEM TO TREAT DEPRESSION AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Krynicki, Carl, et al.
Publicado: (2018)

The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
por: Deakin, Bill, et al.
Publicado: (2018)

30. AN IMMUNE PATHOGENESIS OF PSYCHOSIS? EVIDENCE AND CHALLENGES FROM BENCH TO BEDSIDE
por: Upthegrove, Rachel
Publicado: (2018)

Health beliefs and carer burden in first episode psychosis
por: Patel, Maya, et al.
Publicado: (2014)

The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
por: Kose, Melisa, et al.
Publicado: (2021)

T14. ASSESSING DIFFERENCES IN INFLAMMATORY MARKERS BETWEEN FIRST EPISODE PSYCHOSIS PATIENTS AND HEALTHY CONTROLS: THE IMPORTANCE OF CONTROLLING FOR CONFOUNDING FACTORS
por: Giordano, Annalisa, et al.
Publicado: (2018)

Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial
por: Herniman, Sarah E., et al.
Publicado: (2023)

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation
por: Aas, Monica, et al.
Publicado: (2014)

The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial
por: Lisiecka, Danuta M, et al.
Publicado: (2015)

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
por: Mondelli, Valeria, et al.
Publicado: (2015)

O8.7. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS AND ASSOCIATION TO TREATMENT RESPONSE
por: Russo, Manuela, et al.
Publicado: (2018)

Serum and gene expression profile of cytokines in first-episode psychosis
por: Di Nicola, Marco, et al.
Publicado: (2013)

Dysglycaemia, Inflammation and Psychosis: Findings From the UK ALSPAC Birth Cohort
por: Perry, Benjamin Ian, et al.
Publicado: (2019)

Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses
por: Rowland, Tobias, et al.
Publicado: (2018)

Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification
por: Palaniyappan, Lena, et al.
Publicado: (2016)

T86. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS: AN EMPIRICAL LONGITUDINAL STUDY OF RELATIONSHIP TO COGNITIVE, SYMPTOM AND FUNCTIONAL OUTCOMES
por: Watson, Andrew, et al.
Publicado: (2018)

Persistent Childhood and Adolescent Anxiety and Risk for Psychosis: A Longitudinal Birth Cohort Study
por: Morales-Muñoz, Isabel, et al.
Publicado: (2022)

S186. THE EFFECTS OF CHILDHOOD TRAUMA ON HIPPOCAMPAL VOLUME IN FIRST EPISODE PSYCHOSIS: DOES CORTISOL PLAY A ROLE?
por: Ciufolini, Simone, et al.
Publicado: (2020)

Brain structure in women at risk of postpartum psychosis: an MRI study
por: Fusté, Montserrat, et al.
Publicado: (2017)

T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives
por: Corsi-Zuelli, Fabiana, et al.
Publicado: (2021)

Altered dynamics of the prefrontal networks are associated with the risk for postpartum psychosis: a functional magnetic resonance imaging study
por: Sambataro, Fabio, et al.
Publicado: (2021)

Social Disadvantage: Cause or Consequence of Impending Psychosis?
por: Stilo, Simona A., et al.
Publicado: (2013)

T130. ASSOCIATIONS BETWEEN DIFFERENT TYPES OF CHILDHOOD ADVERSITY AND 5-YEAR OUTCOMES IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ajnakina, Olesya, et al.
Publicado: (2018)

White matter integrity as a predictor of response to treatment in first episode psychosis
por: Reis Marques, Tiago, et al.
Publicado: (2014)

Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study
por: Ajnakina, Olesya, et al.
Publicado: (2017)

Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude?
por: Dazzan, Paola
Publicado: (2014)

A comparison between self-report and interviewer-rated retrospective reports of childhood abuse among individuals with first-episode psychosis and population-based controls
por: Gayer-Anderson, Charlotte, et al.
Publicado: (2020)

Postpartum psychosis: A proposed treatment algorithm
por: Jairaj, Chaitra, et al.
Publicado: (2023)

Do Defective Immune System-Mediated Myelination Processes Increase Postpartum Psychosis Risk?
por: Dazzan, Paola, et al.
Publicado: (2018)

Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis
por: Ajnakina, Olesya, et al.
Publicado: (2014)

Differential gene expression analysis in blood of first episode psychosis patients
por: Leirer, Daniel J., et al.
Publicado: (2019)

Recognition and management of depression in early psychosis
por: Bashir, Zainab, et al.
Publicado: (2022)

Self-guided Cognitive Behavioral Therapy Apps for Depression: Systematic Assessment of Features, Functionality, and Congruence With Evidence
por: Martinengo, Laura, et al.
Publicado: (2021)

Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis
por: Foley, Éimear M, et al.
Publicado: (2023)

Further evidence of a cumulative effect of social disadvantage on risk of psychosis
por: Stilo, S. A., et al.
Publicado: (2017)

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?
por: Hepgul, Nilay, et al.
Publicado: (2013)

Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study
por: Reininghaus, Ulrich, et al.
Publicado: (2016)

Contents of volume 301 (2005)
Publicado: (2005)

Health Tract, No. 301: Acidity
Publicado: (1867)

Cannot write session to /tmp/vufind_sessions/sess_aab50trnmkg684osfqe7br8sk6